Cargando…

Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion

Precision medicine has been getting more attention in lung cancer treatment. Here, we report an unusual case of a 71-year-old Chinese male patient with poorly differentiated lung adenocarcinoma with lymph node metastasis. A 5 years' treatment history of this patient is reported. By serial genet...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Zhihua, Mu, Tianhao, Liu, Longying, Rao, Jingjie, Jin, Min, Wang, Zhizheng, Wang, Hui, Lu, Chao, Gong, Xiaolin, Zheng, Dongcai, Zheng, Daoming, Li, Xin, Li, Yingmei, Chen, Shifu, Shu, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645070/
https://www.ncbi.nlm.nih.gov/pubmed/33194628
http://dx.doi.org/10.3389/fonc.2020.561341
_version_ 1783606589249290240
author Miao, Zhihua
Mu, Tianhao
Liu, Longying
Rao, Jingjie
Jin, Min
Wang, Zhizheng
Wang, Hui
Lu, Chao
Gong, Xiaolin
Zheng, Dongcai
Zheng, Daoming
Li, Xin
Li, Yingmei
Chen, Shifu
Shu, Xinhua
author_facet Miao, Zhihua
Mu, Tianhao
Liu, Longying
Rao, Jingjie
Jin, Min
Wang, Zhizheng
Wang, Hui
Lu, Chao
Gong, Xiaolin
Zheng, Dongcai
Zheng, Daoming
Li, Xin
Li, Yingmei
Chen, Shifu
Shu, Xinhua
author_sort Miao, Zhihua
collection PubMed
description Precision medicine has been getting more attention in lung cancer treatment. Here, we report an unusual case of a 71-year-old Chinese male patient with poorly differentiated lung adenocarcinoma with lymph node metastasis. A 5 years' treatment history of this patient is reported. By serial genetic tests of circulating tumor DNA (ctDNA) from peripheral blood and sediment cell genomic DNA (PE-sDNA) from pleural effusion, a novel chronological combination treatment of icotinib, osimertinib, and crizotinib was adopted for the present genetic mutations, including EGFR exon 19 deletion, EGFR p.T790M, and MET amplification.
format Online
Article
Text
id pubmed-7645070
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76450702020-11-13 Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion Miao, Zhihua Mu, Tianhao Liu, Longying Rao, Jingjie Jin, Min Wang, Zhizheng Wang, Hui Lu, Chao Gong, Xiaolin Zheng, Dongcai Zheng, Daoming Li, Xin Li, Yingmei Chen, Shifu Shu, Xinhua Front Oncol Oncology Precision medicine has been getting more attention in lung cancer treatment. Here, we report an unusual case of a 71-year-old Chinese male patient with poorly differentiated lung adenocarcinoma with lymph node metastasis. A 5 years' treatment history of this patient is reported. By serial genetic tests of circulating tumor DNA (ctDNA) from peripheral blood and sediment cell genomic DNA (PE-sDNA) from pleural effusion, a novel chronological combination treatment of icotinib, osimertinib, and crizotinib was adopted for the present genetic mutations, including EGFR exon 19 deletion, EGFR p.T790M, and MET amplification. Frontiers Media S.A. 2020-10-23 /pmc/articles/PMC7645070/ /pubmed/33194628 http://dx.doi.org/10.3389/fonc.2020.561341 Text en Copyright © 2020 Miao, Mu, Liu, Rao, Jin, Wang, Wang, Lu, Gong, Zheng, Zheng, Li, Li, Chen and Shu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Miao, Zhihua
Mu, Tianhao
Liu, Longying
Rao, Jingjie
Jin, Min
Wang, Zhizheng
Wang, Hui
Lu, Chao
Gong, Xiaolin
Zheng, Dongcai
Zheng, Daoming
Li, Xin
Li, Yingmei
Chen, Shifu
Shu, Xinhua
Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
title Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
title_full Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
title_fullStr Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
title_full_unstemmed Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
title_short Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
title_sort case report: a chronological combination treatment of icotinib, osimertinib, and crizotinib on lung adenocarcinoma guided by serial genetic tests of circulating tumor dna and sediment cell genomic dna from pleural effusion
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645070/
https://www.ncbi.nlm.nih.gov/pubmed/33194628
http://dx.doi.org/10.3389/fonc.2020.561341
work_keys_str_mv AT miaozhihua casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT mutianhao casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT liulongying casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT raojingjie casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT jinmin casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT wangzhizheng casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT wanghui casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT luchao casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT gongxiaolin casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT zhengdongcai casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT zhengdaoming casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT lixin casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT liyingmei casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT chenshifu casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion
AT shuxinhua casereportachronologicalcombinationtreatmentoficotinibosimertinibandcrizotinibonlungadenocarcinomaguidedbyserialgenetictestsofcirculatingtumordnaandsedimentcellgenomicdnafrompleuraleffusion